MISSISSAUGA, Ontario, May 08, 2020 (GLOBE NEWSWIRE) — KP Tissue Inc. (KPT) (TSX: KPT) reports the Q1 2020 financial and operational results of KPT and Kruger Products L.P. (KPLP). Kruger Products is Canada’s leading manufacturer of quality tissue products for the Consumer market (Cashmere, Purex, SpongeTowels, Scotties, and White Swan) and the Away-From-Home market, and continues to grow in the U.S. Consumer tissue business with the White Cloud® brand and premium private label products. KPT currently holds a 14.8% interest in KPLP.KPLP Q1 2020 Business and Financial HighlightsRevenue increased by $24.1 million or 6.9% to $375.1 million in Q1 2020 compared to $351.0 million in Q1 2019. Excluding the divested Mexico business, Q1 2020 revenue increased by $50.2 million or 15.5%.Adjusted EBITDA was $51.0 million in Q1 2020 compared to $23.6 million in Q1 2019, an increase of 116.4%.TAD Sherbrooke site temporarily shutdown for one month due to COVID-19 pandemic, progressing well after restart.Declared a quarterly dividend of $0.18 per share to be paid on July 15, 2020.“In response to COVID-19, our company activated our pandemic response and business continuity plans early to ensure we could meet the increased demands while keeping our people safe. Our primary focus is on the safety of our people and we implemented significant practices to ensure we meet this challenge. On business continuity we have built several contingency plans and increased raw material supplies to manage any potential disruption,” stated KP Tissue Chief Executive Officer, Dino Bianco.“We no doubt had an exceptional quarter driven by unprecedented consumer demand for all our products due to the COVID-19 pandemic. As a result, Adjusted EBITDA was $51.0 million, up 116% over last year. We are proud that our employees successfully managed the tremendous surge in demand, under very challenging conditions and with all the uncertainty surrounding the COVID-19 crisis. Our plants ran full out to keep pace and performed very well, so we could continue to deliver essential products to our valued customers and consumers. This performance also reflects the benefits and progress of the OpEx program put in place early last year.“We saw increased demand in all our categories as consumers stocked up and used more product at home given work from home mandates and increased hygiene, particularly in paper towels and facial tissue. We expect this demand spike will partially reverse in the coming months as consumers get back to work and are well stocked on tissue products. The Away-from-Home (“AFH”) segment is expected to face strong headwinds as end user markets have been severely impacted by COVID-19.“Work on the TAD Sherbrooke construction site was temporarily halted for COVID-19 but resumed in late April. At this stage, we believe this interruption will not have any material impact on the timeline and budget of this project. The pandemic has clearly heightened the strategic importance of the TAD Sherbrooke facility and the new capacity it provides,” concluded Mr. Bianco.Outlook
Our business remains strong based on high demand for our products, particularly in the Consumer segment, and continued favourable input costs compared to 2019. Considering the risk and uncertainties associated with the COVID-19 pandemic and the impacts it could have on our operations, the company is providing the following general range of guidance for Q2 2020. The Adjusted EBITDA is expected to be in a range that is lower than Q1 2020 and higher than Q2 2019.KPLP Q1 2020 Financial Results
Revenue was $375.1 million in Q1 2020 compared to $351.0 million in Q1 2019, an increase of $24.1 million or 6.9%. The increase in revenue was primarily due to volume increases in Canada and the U.S., resulting primarily from COVID-19 buying activity, and the impact of favourable sales mix, partially offset by lower prices in the Consumer segment and no volume from Mexico as a result of the share sale at the end of Q3 2019. Mexico revenue in Q1 2019 was $26.1 million. Excluding the Mexico business, revenue increased by $50.2 million or 15.5%.Cost of sales was $314.5 million in Q1 2020 compared to $320.1 million in Q1 2019, a decrease of $5.6 million or 1.7%. Manufacturing costs decreased primarily due to favourable pulp costs and lower outsourced manufacturing activity compared to Q1 2019, partially offset by inflation and additional maintenance costs, in part due to precautions taken in our manufacturing facilities as a result of COVID-19. Freight and warehousing costs both increased compared to Q1 2019. As a percentage of revenue, cost of sales was 83.8% in Q1 2020 compared to 91.2% in Q1 2019.Selling, general and administrative (SG&A) expenses were $29.6 million in Q1 2020 compared to $22.1 million in Q1 2019, an increase of $7.5 million or 34.4%. The increase was primarily due to higher compensation related costs compared to Q1 2019, higher selling expenses and increased advertising and promotion expenses. As a percentage of revenue, SG&A expenses were 7.9% in Q1 2020 compared to 6.3% in Q1 2019.Adjusted EBITDA was $51.0 million in Q1 2020 compared to $23.6 million in Q1 2019, an increase of $27.4 million or 116.4%. The increase was primarily due to higher sales volume and favourable sales mix, and the favourable impact of lower pulp prices and lower outsourced manufacturing compared to Q1 2019, partially offset by higher logistics and SG&A costs.Net income was $8.4 million in Q1 2020 compared to a net loss of $3.2 million in Q1 2019, an increase of $11.6 million. The increase was primarily due to higher Adjusted EBITDA, partially offset by a foreign exchange loss on USD debt, expense from the change in amortized cost of partnership units liability and consulting costs related to operational transformation initiatives.KPLP Q1 2020 Financing Activity
In response to the uncertainty resulting from the COVID-19 pandemic, KPLP entered into discussions with the TAD Sherbrooke Borrowing Group lenders to amend certain terms of the agreement to provide greater flexibility for the project. As a result, the first amendment to the credit agreement was completed and closed on April 20, 2020 with an effective date of March 23, 2020.Total liquidity, representing cash and availability under the Senior Credit Facility within covenant limitations, was $217.7 million as of March 31, 2020. In addition, $42.5 million of cash was held by KPSI and committed to the TAD Sherbrooke Project.KPT Q1 2020 Financial Results
KPT had net income of $1.7 million in Q1 2020. Included in net income was $1.3 million representing KPT’s share of KPLP’s net income, depreciation expense of $1.4 million related to adjustments to carrying amounts on acquisition and an income tax recovery of $1.6 million.Dividends on Common Shares
The Board of Directors of KPT declared a quarterly dividend of $0.18 per share to be paid on July 15, 2020 to shareholders of record at the close of business on July 3, 2020.Additional Information
For additional information please refer to Management’s Discussion and Analysis (MD&A) of KPT and KPLP for the first quarter ended March 31, 2020 available on SEDAR at www.sedar.com or our website at www.kptissueinc.com.First Quarter Results Conference Call Information
KPT will hold its first quarter conference call on Friday, May 8, 2020 at 8:30 a.m. Eastern Time.Via telephone: 1-877-223-4471 or 647-788-4922Via the internet at: www.kptissueinc.comPresentation material referenced during the conference call will be available at www.kptissueinc.com.A rebroadcast of the conference call will be available until midnight, May 15, 2020 by dialing 1-800-585-8367 or 416-621-4642 and entering passcode 6936809.The replay of the webcast will remain available on the website until midnight, May 15, 2020.About KP Tissue Inc. (KPT)
KPT was created to acquire, and its business is limited to holding, a limited partnership interest in KPLP, which is accounted for as an investment on the equity basis. KPT currently holds a 14.8% interest in KPLP. For more information visit www.kptissueinc.com.About Kruger Products L.P. (KPLP)
KPLP is Canada’s leading manufacturer of quality tissue products for household, industrial and commercial use. KPLP serves the Canadian consumer market with such well-known brands as Cashmere®, Purex®, SpongeTowels®, Scotties® and White Swan®. In the U.S., KPLP manufactures the White Cloud® brand, as well as many private label products. The Away-From-Home division manufactures and distributes high-quality, cost-effective product solutions to a wide range of commercial and public entities. KPLP has approximately 2,500 employees and operates eight FSC® COC-certified (FSC® C-104904) production facilities in North America. For more information visit www.krugerproducts.ca.Non-IFRS Measures
This press release uses certain non-IFRS financial measures which KPLP believes provide useful information to management of KPLP and the readers of the financial information in measuring the financial performance and financial condition of KPLP. These measures do not have a standardized meaning prescribed by IFRS and therefore may not be comparable to similarly titled measures presented by other companies. An example of such a measure is Adjusted EBITDA. Beginning with Q4 2015 in accordance with Canadian Securities Administrators Staff Notice 52-306 (Revised), we have referenced Adjusted EBITDA as a non-IFRS financial measure. This term replaces the previously referenced non-IFRS financial measure EBITDA. Adjusted EBITDA is not a measurement of operating performance computed in accordance with IFRS and should not be considered as a substitute for operating income, net income or cash flows from operating activities computed in accordance with IFRS. “Adjusted EBITDA” is calculated by KPLP as net income (loss) before (i) interest expense, (ii) income taxes, (iii) depreciation, (iv) amortization, (v) impairment (gain on sale) of non-financial assets, (vi) loss (gain) on disposal of property, plant and equipment, (vii) foreign exchange loss (gain), (viii) costs related to restructuring activities, (ix) changes in amortized cost of Partnership units liability, (x) change in fair value of derivatives, (xi) consulting costs related to operational transformation initiatives, (xii) corporate development related costs and (xiii) loss (gain) on sale of shares. A reconciliation of Adjusted EBITDA to the relevant reported results can be found in the MD&A of KPT and KPLP for the year ended December 31, 2019 available on SEDAR at www.sedar.com.COVID-19
In March 2020, the World Health Organization characterized the outbreak of the novel strain of coronavirus, specifically identified as “COVID-19” as a global pandemic. This has resulted in the local governments enacting emergency measures to combat the spread of the virus. These measures, which include the implementation of travel bans, self-imposed quarantine periods and social distancing, have caused material disruption to businesses in the United States of America and Canada resulting in an economic slowdown. Equity markets have experienced significant volatility and weakness and the local governments and central banks have reacted with significant monetary and fiscal interventions designed to stabilize economic conditions. There is significant uncertainty as to the likely effects of this outbreak. The duration and impact of the COVID-19 outbreak is unknown at this time, as is the efficacy of the government and central bank interventions. It is not possible to reliably estimate the length and severity of these developments to quantify the impact this pandemic may have on the financial results and condition of KPLP in future periods.Forward-Looking Statements
Certain statements in this press release about KPT’s and KPLP’s current and future plans, expectations and intentions, results, levels of activity, performance, goals or achievements or any other future events or developments constitute forward-looking statements. Forward-looking statements in this press release include, but are not limited to, statements regarding the projected capacity of the TAD Sherbrooke Project, the anticipated benefits of the TAD Sherbrooke Project and the expected dates for commencement of construction and production of the TAD Sherbrooke Project. The words “may”, “will”, “would”, “should”, “could”, “expects”, “plans”, “intends”, “trends”, “indications”, “anticipates”, “believes”, “estimates”, “predicts”, “likely” or “potential” or the negative or other variations of these words or other comparable words or phrases, are intended to identify forward-looking statements. The forward-looking statements are based on certain key expectations and assumptions made by KPT or KPLP. Although KPT and KPLP believe that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking statements since no assurance can be given that such expectations and assumptions will prove to be correct.The outlook provided in respect of Adjusted EBITDA for Q2 2020 is forward-looking information and is subject to the risk and uncertainties referred to below. The purpose of the outlook is to provide the reader with an indication of management’s expectations, at the date of this press release, regarding KPLP’s future financial performance. Readers are cautioned that this information may not be appropriate for other purposes.Many factors could cause KPLP’s actual results, level of activity, performance or achievements or future events or developments (which could in turn affect the economic benefits derived from KPT’s economic interest in KPLP), to differ materially from those expressed or implied by the forward-looking statements, including, without limitation, the following factors, which are discussed in greater detail in the “Risk Factors – Risks Related to KPLP’s Business” section of the KPT Annual Information Form dated March 30, 2020 available on SEDAR at www.sedar.com: Kruger Inc.’s influence over KPLP; KPLP’s reliance on Kruger Inc.; consequences of an event of insolvency relating to Kruger Inc.; risks associated with the TAD Sherbrooke Project; operational risks; significant increases in input costs; reduction in supply of fibre; increased pricing pressure and intense competition; KPLP’s inability to innovate effectively; adverse economic conditions; dependence on key retail trade customers; damage to the reputation of KPLP or KPLP’s brands; KPLP’s sales being less than anticipated; KPLP’s failure to implement its business and operating strategies; KPLP’s obligation to make regular capital expenditures; KPLP’s entering into unsuccessful acquisitions; KPLP’s dependence on key personnel; KPLP’s inability to retain its existing customers or obtain new customers; KPLP’s loss of key suppliers; KPLP’s failure to adequately protect its intellectual property rights; KPLP’s reliance on third party intellectual property licenses; adverse litigation and other claims affecting KPLP; material expenditures due to comprehensive environmental regulation affecting KPLP’s cash flow; KPLP’s pension obligations are significant and can be materially higher than predicted if KPLP Management’s underlying assumptions are incorrect; labour disputes adversely affecting KPLP’s cost structure and KPLP’s ability to run its plants; exchange rate and U.S. competitors; KPLP’s inability to service all of its indebtedness; exposure to potential consumer product liability; covenant compliance; interest rate and refinancing risk; risks relating to information technology; cyber-security; insurance; internal controls; trade; and risks related to COVID-19.Readers should not place undue reliance on forward-looking statements made herein. The forward-looking information contained herein is expressly qualified in its entirety by this cautionary statement. The forward-looking information contained herein is made as of the date of press release and KPT undertakes no obligation to publicly update such forward-looking information to reflect new information, subsequent or otherwise, unless required by applicable securities laws.INFORMATION:Francois Paroyan
General Counsel and Corporate Secretary
KP Tissue Inc.
Tel.: 905.812.6936
[email protected]INVESTORS:Mike Baldesarra
Director of Investor Relations
KP Tissue Inc.
Tel.: 905.812.6962
[email protected]






Bay Street News